News

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Pharmaceutical Technology on MSN18h
Merck KGaA strikes $3.9bn deal for SpringWorks
Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks ...
In a press release, Merck KGaA CEO and chair of the executive board Belen Garijo said, “The agreed acquisition of SpringWorks is a major step in our active portfolio strategy to position Merck KGaA, ...
Current health news highlights include a dispute over EU drug pricing proposals, a U.S.-Mexico accord on screwworm management ...
A German pharmaceutical company is acquiring a drug developer with operations in Research Triangle Park.